Provider of a wearable platform for treating vertigo and motion sickness. The platform is meant for travelers and virtual reality users. The company leverages its proprietary technology for addressing the problem of the vestibular system and eye control balance which causes vertigo and motion sickness. The company was founded in 2015 and headquartered in Washington, United States. It has raised $33.8M in series a funding, with backing from Morningside, MedTech Innovator. The company operates in the Life Sciences - ENT Disorders, High Tech - Wearable Technology space. The company leverages advanced technology to deliver innovative solutions tailored to its target market, addressing key industry challenges and driving value for its customers.
← All startups
Otolith Labs
Series AProvider of a wearable platform for treating vertigo and motion sickness. The platform is meant for travelers and virtual reality users. The company leverages its proprietary technology for addressing the problem of the vestibular system and eye control balance which causes vertigo and motion sickness. The company was founded in 2015 and headquartered in Washington, United States. It has raised $33.8M in series a…
About
Business model
Wearable Technology > Health and Wellness Devices > Ear Care > Vertigo Treatment,
ENT Disorders > Medical Devices > Therapeutic Devices > Ear > Neurotology > Vertigo > Wearable
Founders & team highlights
Serial Founder
Institutional investors
MorningsideMedTech InnovatorMark Cuban
Latest coverage
📰 See all funding news — keep up with the raises that set comps.
Investor directory
🗂️ Explore Life Sciences investors — funds that write checks in this sector.